Effects of moxonidine on sympathetic nervous system activity: An update on metabolism, cardio, and other target-organ protection

Moxonidine is the newest, second-generation, centrally acting antihypertensive agent. It has selective agonist activity at imidazoline I1 receptors and less adverse effects than the other centrally acting drugs. This fact authorizes the frequent use of moxonidine in clinical practice, as monotherapy...

Full description

Bibliographic Details
Main Authors: Eleni F Karlafti, Apostolos I Hatzitolios, Anastasios F Karlaftis, Maria S Baltatzi, Georgios G Koliakos, Christos G Savopoulos
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2013-01-01
Series:Journal of Pharmacy and Bioallied Sciences
Subjects:
Online Access:http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2013;volume=5;issue=4;spage=253;epage=256;aulast=Karlafti